rdf:type |
|
lifeskim:mentions |
umls-concept:C0010592,
umls-concept:C0017968,
umls-concept:C0019704,
umls-concept:C0036667,
umls-concept:C0312418,
umls-concept:C1514873,
umls-concept:C1521840,
umls-concept:C1550548,
umls-concept:C1555714,
umls-concept:C1623048,
umls-concept:C1704259,
umls-concept:C1705654,
umls-concept:C1705987
|
pubmed:issue |
8
|
pubmed:dateCreated |
1997-7-31
|
pubmed:abstractText |
Human immunodeficiency virus type 1 (HIV-1) normally enters cells by direct fusion with the plasma membrane. In this report, HIV-1 particles capable of infecting cells through an endocytic pathway are described. Chimeric viruses composed of the HIV-1 core and the envelope glycoprotein of vesicular stomatitis virus (VSV-G) were constructed and are herein termed HIV-1(VSV) pseudotypes. HIV-1(VSV) pseudotypes were 20- to 130-fold more infectious than nonpseudotyped HIV-1. Infection by HIV-1(VSV) pseudotypes was markedly diminished by ammonium chloride and concanamycin A, a selective inhibitor of vacuolar H+ ATPases, demonstrating that these viruses require endosomal acidification to achieve productive infection. HIV-1 is thus capable of performing all of the viral functions necessary for infection when entry is targeted to an endocytic route. Maximal HIV-1 infectivity requires the presence of the viral Nef protein and the cellular protein cyclophilin A (CyPA) during virus assembly. Pseudotyping by VSV-G markedly suppressed the requirement for Nef. HIV-1(VSV) particles were also resistant to inhibition by cyclosporin A; however, the deleterious effect of a gag mutation inhibiting CyPA incorporation was not relieved by VSV-G. These results suggest that Nef acts at a step of the HIV-1 life cycle that is either circumvented or facilitated by targeting virus entry to an endocytic pathway. The findings also support the hypothesis that Nef and CyPA enhance HIV-1 infectivity through independent processes and demonstrate a mechanistic difference between reduction of HIV-1 infectivity by cyclosporin A and gag mutations that decrease HIV-1 incorporation of CyPA.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1374685,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1386485,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1470916,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1548759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1560526,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1845882,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-1847450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-2032289,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-2142306,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-2398460,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-2676192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3016298,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3094962,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3107838,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3259178,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3261635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3262112,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-3492611,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-6288961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-6361463,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7494343,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7539505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7541845,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7571414,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7585960,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7687060,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7859280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7969494,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7969495,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-7983759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8124721,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8151761,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8270859,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8396259,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8413583,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8602510,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8642659,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8648689,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8676450,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8710859,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9223476-8986799
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acid Isomerases,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/G protein, vesicular stomatitis...,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, gag,
http://linkedlifedata.com/resource/pubmed/chemical/Gene Products, nef,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidylprolyl Isomerase,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Envelope Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/nef Gene Products, Human...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-538X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
71
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5871-7
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9223476-Amino Acid Isomerases,
pubmed-meshheading:9223476-Carrier Proteins,
pubmed-meshheading:9223476-Cyclosporine,
pubmed-meshheading:9223476-Endocytosis,
pubmed-meshheading:9223476-Gene Products, gag,
pubmed-meshheading:9223476-Gene Products, nef,
pubmed-meshheading:9223476-HIV-1,
pubmed-meshheading:9223476-Humans,
pubmed-meshheading:9223476-Immunosuppressive Agents,
pubmed-meshheading:9223476-Membrane Glycoproteins,
pubmed-meshheading:9223476-Peptidylprolyl Isomerase,
pubmed-meshheading:9223476-Viral Envelope Proteins,
pubmed-meshheading:9223476-nef Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
1997
|
pubmed:articleTitle |
Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2363, USA. chris.aiken@mcmail.vanderbilt.edu
|
pubmed:publicationType |
Journal Article
|